LUPKYNIS
In January 2021, Aurinia Introduced LUPKYNIS® (voclosporin), the First FDA-Approved Oral Therapy for the Treatment of Adult Patients with Active Lupus Nephritis
- https://www.lupkynis.com/
- Full Prescribing Information including Boxed WARNING
- LUPKYNIS English Medication Guide
- LUPKYNIS Spanish Medication Guide
If you are a healthcare provider and would like to request information on LUPKYNIS, contact us at Medinfo@auriniapharma.com.